Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 47 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 41 | 1,657−1.3%/yr | −1.3%/yr | 3.61.1× | 2% | 1,880 in 2030+2.1%/yr |
| Decompression & minimally invasive spine | 39 | 1,508−11%/yr | −11%/yr | 3.31.0× | 4% | 1,590 in 2030+0.9%/yr |
| Cervical fusion & disc arthroplasty | 31 | 919−9.6%/yr | −9.6%/yr | 2.01.2× | 4% | 880 in 2030−0.7%/yr |
| Kyphoplasty & vertebroplasty | 5 | 752−5.3%/yr | −5.3%/yr | 1.71.0× | 33% | 680 in 2030−1.7%/yr |
| SI joint fusion | 1 | 100+11%/yr | +11%/yr | 0.20.6× | 0% | 60 in 2030−8.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 164 | 36,065−4.8%/yr | −4.8%/yr | 77.60.6× | 30% | 39,500 in 2030+1.5%/yr |
| Skin substitutes & wound grafts | 31 | 7,567+19%/yr | +19%/yr | 9.40.8× | 82% | 11,800 in 2030+7.7%/yr |
| Bone graft & orthobiologics | 10 | 293−20%/yr | −20%/yr | 0.60.9× | 4% | 290 in 20300%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 71 | 4,863+1.6%/yr | +1.6%/yr | 10.50.7× | 74% | 6,430 in 2030+4.8%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 6 | 319+4.8%/yr | +4.8%/yr | 0.70.5× | 49% | 670 in 2030+13%/yr |
| Spinal cord & DRG stimulation | 4 | 201−12%/yr | −12%/yr | 0.40.4× | 35% | 180 in 2030−1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 19 | 2,322−11%/yr | −11%/yr | 5.00.8× | 47% | 2,130 in 2030−1.4%/yr |
| Dialysis access | 35 | 2,267−19%/yr | −19%/yr | 5.41.0× | 57% | 2,000 in 2030−2.1%/yr |
| Superficial venous ablation | 29 | 2,003−5.2%/yr | −5.2%/yr | 4.30.7× | 85% | 2,070 in 2030+0.6%/yr |
| Thrombectomy, IVC filters & venous stents | 7 | 675−4.4%/yr | −4.4%/yr | 1.60.9× | 12% | 640 in 2030−1%/yr |
| Carotid revascularization | 13 | 603−11%/yr | −11%/yr | 1.31.0× | 0% | 600 in 2030−0.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 218−11%/yr | −11%/yr | 0.51.0× | 0% | 230 in 2030+1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 23 | 2,616−6.7%/yr | −6.7%/yr | 6.41.0× | 5% | 2,470 in 2030−1%/yr |
| Cholecystectomy & appendectomy | 49 | 2,132−10%/yr | −10%/yr | 5.01.1× | 4% | 1,870 in 2030−2.2%/yr |
| Colorectal resection | 7 | 775−8.2%/yr | −8.2%/yr | 1.81.1× | 0% | 760 in 2030−0.3%/yr |
| Antireflux & hiatal hernia surgery | 4 | 373−3%/yr | −3%/yr | 0.81.1× | 0% | 430 in 2030+2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 53 | 2,415−5.4%/yr | −5.4%/yr | 5.61.1× | 8% | 2,290 in 2030−0.9%/yr |
| BPH procedures | 14 | 1,324−10%/yr | −10%/yr | 3.00.6× | 18% | 940 in 2030−5.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 17 | 1,302−0.1%/yr | −0.1%/yr | 2.91.1× | 16% | 1,480 in 2030+2.2%/yr |
| Hysterectomy, hysteroscopy & ablation | 8 | 942−6.1%/yr | −6.1%/yr | 2.40.9× | 13% | 900 in 2030−0.8%/yr |
| Prostatectomy & nephrectomy | 5 | 469−7.9%/yr | −7.9%/yr | 1.21.0× | 0% | 440 in 2030−1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 30 | 3,147−2.3%/yr | −2.3%/yr | 7.31.4× | 85% | 3,630 in 2030+2.4%/yr |
| Ear tubes & middle ear surgery | 5 | 326−8.6%/yr | −8.6%/yr | 0.82.4× | 70% | 320 in 2030−0.5%/yr |
| Sleep apnea & airway implants | 3 | 154+128%/yr | +128%/yr | 0.31.4× | 0% | 140 in 2030−1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 36 | 2,322−3.8%/yr | −3.8%/yr | 5.70.8× | 10% | 2,460 in 2030+1%/yr |
| Tumor & fibroid embolization | 5 | 198+0.2%/yr | +0.2%/yr | 0.50.8× | 68% | 810 in 2030+26%/yr |
| Tumor ablation | 0 | 110+2.3%/yr | +2.3%/yr | 0.30.8× | 0% | 140 in 2030+4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 73 | 11,837+23%/yr | +23%/yr | 26.40.9× | 81% | 19,400 in 2030+8.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 51 | 2,358−6.8%/yr | −6.8%/yr | 5.61.0× | 0% | 2,180 in 2030−1.3%/yr |
| EP ablation | 36 | 2,013+2.1%/yr | +2.1%/yr | 3.71.0× | 0% | 2,930 in 2030+6.5%/yr |
| LAA occlusion & loop recorders | 39 | 1,517+9.2%/yr | +9.2%/yr | 2.90.8× | 6% | 2,190 in 2030+6.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 83 | 3,251−13%/yr | −13%/yr | 5.81.0× | 0% | 3,010 in 2030−1.3%/yr |
| Structural heart (TAVR, TEER) | 44 | 739−2.6%/yr | −2.6%/yr | 1.40.9× | 0% | 660 in 2030−1.9%/yr |
| Mechanical circulatory support | 1 | 254−13%/yr | −13%/yr | 0.61.0× | 0% | 240 in 2030−1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 6 | 207+12%/yr | +12%/yr | 0.51.1× | 0% | 180 in 2030−1.9%/yr |
| Aneurysm & intracranial embolization | 6 | 196+34%/yr | +34%/yr | 0.41.0× | 0% | 300 in 2030+7.4%/yr |
| DBS & VNS | 4 | 187−6.5%/yr | −6.5%/yr | 0.41.3× | 0% | 190 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 102 | 35,688−2.7%/yr | −2.7%/yr | 79.51.4× | 83% | 29,500 in 2030−3.1%/yr |
| Vitreoretinal surgery | 18 | 1,215−6.6%/yr | −6.6%/yr | 2.81.1× | 45% | 1,170 in 2030−0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 240 | 44,415−7.6%/yr | −7.6%/yr | 105.80.9× | 42% | 41,100 in 2030−1.3%/yr |
| ERCP & endoscopic ultrasound | 21 | 1,343−4.1%/yr | −4.1%/yr | 3.10.9× | 11% | 1,700 in 2030+4%/yr |
| Bronchoscopy & lung nodule | 19 | 1,031+1.9%/yr | +1.9%/yr | 2.40.7× | 0% | 1,640 in 2030+8%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.